Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 03 - 01    symbols : Abbv    save search

JAK Inhibitors Market to Grow by USD 12.05 billion | Increasing Number of Awareness Campaigns to Boost Growth | Technavio
Published: 2022-03-01 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 2.02% C: 2.02%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 1.39% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K twitter stocktwits trandingview |
Manufacturing
| | O: -1.17% H: 0.68% C: 0.68%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 2.4% C: 1.27%
GLPG | News | $29.095 0.64% 0.64% 87K twitter stocktwits trandingview |
Health Technology
| | O: -2.66% H: 0.35% C: -1.83%
CTIC | $9.09 0.05% 11M twitter stocktwits trandingview |
Health Technology
| | O: 6.03% H: 13.88% C: 12.71%
AZN | News | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.62% H: 0.0% C: 0.0%

growth
AbbVie Bolsters Neuro Platform with $1B Syndesi Buy
Published: 2022-03-01 (Crawled : 20:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

platform
AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.36% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

therapeutics
AbbVie to Present at the Cowen 42nd Annual Health Care Conference
Published: 2022-03-01 (Crawled : 14:30) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

health conference
Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Eight Additional European Countries
Published: 2022-03-01 (Crawled : 10:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

europe application authorization submission
Gainers vs Losers
67% 33%

Top 10 Gainers

Your saved searches
Save your searches and get alerts when important news are released.